Factive and Hyperhidrosis - a phase IV clinical study of FDA data

Summary:

Hyperhidrosis is reported as a side effect among people who take Factive (gemifloxacin mesylate), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Levaquin, and have Respiratory tract infection bacterial.

The phase IV clinical study analyzes which people have Hyperhidrosis when taking Factive. It is created by eHealthMe based on reports of 1,420 people who have side effects when taking Factive from the FDA, and is updated regularly.

What is Factive?

Factive has active ingredients of gemifloxacin mesylate. eHealthMe is studying from 1,430 Factive users. Check the latest studies of Factive.

What is Hyperhidrosis?

Hyperhidrosis (abnormally increased sweating) is found to be associated with 2,578 drugs and 3,529 conditions by eHealthMe. Check the latest studies of Hyperhidrosis.

On Dec, 10, 2025

1,420 people reported to have side effects when taking Factive.
Among them, 12 people (0.85%) have Hyperhidrosis.

Among these 12 people:

How long have people been on Factive when they have Hyperhidrosis? *

What is the gender of people who have Hyperhidrosis when taking Factive? *

female: 50 %
male: 50 %

What is the age of people who have Hyperhidrosis when taking Factive? *

What are other drugs people take besides Factive? *

What are other side effects people have besides Hyperhidrosis? *

Nausea (feeling of having an urge to vomit): 4 people, 33.33%
Headache (pain in head): 4 people, 33.33%
Weakness: 4 people, 33.33%
Hypoaesthesia (reduced sense of touch or sensation): 3 people, 25.00%
Dysstasia (difficulty in standing): 3 people, 25.00%
Pain: 3 people, 25.00%
Fatigue (feeling of tiredness): 3 people, 25.00%
Blood Chloride Decreased: 3 people, 25.00%
Dyspnea (difficult or laboured breathing): 2 people, 16.67%
Drug Ineffective: 2 people, 16.67%

What are the existing conditions these people have? *

Respiratory Tract Infection Bacterial: 6 people, 50.00%
Sinusitis (inflammation of sinus): 1 person, 8.33%
Respiratory Tract Infection: 1 person, 8.33%
Pneumonia: 1 person, 8.33%
Lobar Pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung): 1 person, 8.33%
Fever: 1 person, 8.33%
Bronchitis Acute (acute inflammation of the mucous membrane in the bronchial tubes): 1 person, 8.33%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Factive and have Hyperhidrosis?

- Check whether Hyperhidrosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Factive:

Factive (1,430 reports)

Hyperhidrosis treatments and more:

Hyperhidrosis (147,206 reports)

Browse all side effects of Factive:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperhidrosis:

Hyperhidrosis (2,578 drugs)

Browse all the conditions that are associated with Hyperhidrosis:

Hyperhidrosis (3,529 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gemifloxacin mesylate (the active ingredients of Factive) and Factive (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.